NONFLUENT VARIANT PRIMARY PROGRESSIVE APHASIA (NFVPPA)
Clinical trials for NONFLUENT VARIANT PRIMARY PROGRESSIVE APHASIA (NFVPPA) explained in plain language.
Never miss a new study
Get alerted when new NONFLUENT VARIANT PRIMARY PROGRESSIVE APHASIA (NFVPPA) trials appear
Sign up with your email to follow new studies for NONFLUENT VARIANT PRIMARY PROGRESSIVE APHASIA (NFVPPA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a pill help people who are losing their speech?
Symptom relief Recruiting nowThis early study tests a drug called neflamapimod in 20 people with a rare brain condition that slowly destroys the ability to speak (primary progressive aphasia). The main goal is to check safety and see if the drug can improve language symptoms. Participants take the drug for s…
Matched conditions: NONFLUENT VARIANT PRIMARY PROGRESSIVE APHASIA (NFVPPA)
Phase: PHASE2 • Sponsor: EIP Pharma Inc • Aim: Symptom relief
Last updated May 26, 2026 11:08 UTC
-
Virtual therapy aims to boost communication in language dementia
Symptom relief Recruiting nowThis study tests a personalized, virtual speech therapy program for 30 adults with primary progressive aphasia (a type of dementia that affects language) and their communication partners. The program combines exercises, strategies, and partner training to improve communication an…
Matched conditions: NONFLUENT VARIANT PRIMARY PROGRESSIVE APHASIA (NFVPPA)
Phase: NA • Sponsor: Maya Henry • Aim: Symptom relief
Last updated May 26, 2026 11:01 UTC